BioNTech to report Q2 2026 financial results and corporate update on August 4, 2026

BioNTech SE will announce its financial results for the second quarter of 2026 on August 4, 2026, followed by a conference call and webcast for investors and the public. The company will provide updates on its financial performance and corporate developments, focusing on its innovative cancer therapies and partnerships with major pharmaceutical firms. This event is important for investors to assess BioNTech's progress in oncology and its strategic collaborations. The webcast and presentation will be accessible on BioNTech's website, with a replay available for 30 days after the call.